TY - JOUR PY - 2020// TI - Is short-term antidepressant treatment effective and safe in bipolar depression? Results from an observational multicenter study JO - Human psychopharmacology A1 - Tundo, Antonio A1 - Musetti, Laura A1 - Del Grande, Claudia A1 - de Filippis, Rocco A1 - Proietti, Luca A1 - Cambiali, Erika A1 - Franceschini, Caterina A1 - Dell'osso, Liliana SP - ePub EP - ePub VL - ePub IS - ePub N2 - OBJECTIVES: To investigate the short-term effectiveness and the short-term and long-term safety of acute antidepressant (AD) treatment of bipolar depression in a naturalistic setting. METHODS: Patients with bipolar (n = 86) or unipolar (n = 111) depression were consecutively recruited and treated with AD (combined with mood stabilizer [MS] and/or second-generation antipsychotics in bipolar depression). Exclusion criteria were mixed depression, high mood instability, previous predominantly mixed depression (both bipolar and unipolar depression), rapid cycling course and previous switch AD-emerging (bipolar depression). RESULTS: After 12 weeks of treatment, no difference was found in remission, response and improvement rates between bipolar and unipolar depression. Concerning short-term safety, switching and suicidality did not differ significantly between the two groups, and no suicide attempt was observed. Concerning long-term safety, patients with bipolar depression had a significant reduction of depressive and total recurrences during the year of follow-up, compared to the year before entering the study, without significant changes in (hypo)mania and mixed depression recurrences, and suicide rates. CONCLUSIONS: Acute AD treatment of bipolar depression is effective in the short-term and safe in the short- and long-term, when administered in combination with MSs and/or second-generation antipsychotics, with a low risk of switch, mixed depression and cycle acceleration.

Language: en

LA - en SN - 0885-6222 UR - http://dx.doi.org/10.1002/hup.2773 ID - ref1 ER -